Research Article

Effects of Dietary Bile Acids on Growth Performance, Lipid Deposition, and Intestinal Health of Rice Field Eel (Monopterus albus) Fed with High-Lipid Diets

Table 1

Formulation and proximate composition of the experimental diets.

Ingredients (%)Diets
ConHLHLLBHLHB

Peruvian steam fish meala35353535
Wheat glutena10101010
Soybean meala5.55.55.55.5
Wheat brana5.665.665.665.66
Chicken meala10101010
Squid pastea3333
Wheat starcha20202020
Fish oil13.93.93.9
Soybean oil13.93.93.9
Ca(H2PO4)21.11.11.11.1
Choline chloride0.70.70.70.7
Multidimensionalb0.150.150.150.15
Multi mineralb1111
Calcium propanoate0.030.030.030.03
Ethoxyquin0.010.010.010.01
Microcrystalline cellulose5.850.050.0250
Bile acidsc000.0250.05
Total100100100100
Proximate analysis (%)
 Moisture11.811.311.811.3
 Ash9.69.89.89.9
 Crude protein42.842.442.442.5
 Crude lipid6.9713.1013.1413.18

aComposition of dry matter (%): peruvian steam fishmeal: crude protein 68.35, crude lipid 7.4; wheat gluten: crude protein 83.06, crude lipid 0.96; soybean meal: crude protein 44.2, crude lipid 1.9; wheat bran: crude protein 15.7, crude lipid 3.9; chicken meal: crude protein 65, crude lipid 10; squid paste: crude protein 30.1, crude lipid 20.72; wheat starch: crude protein 0.76, crude lipid 0.19. These ingredients were provided by Jiangxi Aohua Industrial (Nanchang, Jiangxi, China). bMultidimensional and multimineral provided by MGO Ter Bio-Tech (Qingdao, Shandong, China). Vitamin and mineral premix composition (mg/kg diet): KCl, 200; KI (1%), 60; CoCl2_6H2O (1%), 50; CuSO4_5 H2O, 30; FeSO4 H2O, 400; ZnSO4 H2O, 400; MnSO4_ H2O, 150; Na2SeO3_5 H2O (1%), 65; MgSO4_ H2O, 2000; zeolite power, 3645.85; VB1, 12; riboflavin, 12; VB6, 8; VB12, 0.05; VK3, 8; inositol, 100; pantothenic acid, 40; nicotinic acid, 50; folic acid, 5; biotin, 0.8; VA, 25; VD3, 5; VE, 50; VC, 100; ethoxyquin, 150; wheat meal, 2 434.15. cBile acids were bought from Shandong Longchang Animal Health Product Co., Ltd. (>95%, Jinan, China): hyodeoxycholic acid + hyocholic acid ≥77%, chenodeoxycholic acid ≥17%. Treatment groups: CON, control group; HL, high lipid diets group; HLLB, high lipid diets supplementing with 0.025% bile acid group; and HLHB, high lipid diets supplementing with 0.05% bile acid group.